Trump's Criticism of Imports Adds to Drugmakers' Headaches

The U.S. pharmaceutical industry is under pressure from the White House to produce more at home, adding to the heat it has felt over drug prices.

from WSJ.com: US Business http://ift.tt/2kLHs67
via IFTTT